Fig. 1From: Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)CONSORT diagram of patient flow in the pooled ACLIFORM and AUGMENT studies. Data for the 400/6Â ÎĽg dose of the FDC are not reported in this paper and can be found elsewhere [23, 24]; AE, adverse event; FDC, aclidinium/formoterol fixed-dose combinationBack to article page